← All Sponsors
SPONSOR

Hangzhou Hanx Biopharmaceuticals, Ltd.

Total Trials
1
Recruiting
1
Phases
Phase 1, Phase 2
Conditions studied: Biliary Tract CancerMelanoma
NCT06708663 Phase 1, Phase 2
Recruiting

HX009+ IN10018 with or Without Standard Chemotherapy for Advanced Solid Tumours

Biliary Tract Cancer
China View Trial →